Practical pharmacology. Part 3. Drug response

Содержание

Слайд 2

Drug response

Drug response

Слайд 3

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance

Слайд 4

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance

Слайд 5

A Response

A

Response

Слайд 6

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance

Слайд 7

A Response A A Side effects Side effects

A

Response

A

A

Side effects

Side effects

Слайд 8

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance

Слайд 9

Intolerance Exaggerated response (magnified pharmacological response) resembling an overdose of a

Intolerance

Exaggerated response
(magnified pharmacological response)
resembling an overdose of a

drug but at normal dose.

It is commonly observed in children

Слайд 10

Causes Pharmacokinetic Renal insufficiency patients taking digoxin Infants due to underdeveloped

Causes

Pharmacokinetic

Renal insufficiency patients taking digoxin

Infants due to underdeveloped

renal, hepatic function,
immature BBB, or low level of plasma proteins
Слайд 11

Causes Pharmacodynamic Thyrotoxic patients, epinephrine

Causes

Pharmacodynamic

Thyrotoxic patients, epinephrine

Слайд 12

Thyroxine

Thyroxine

Слайд 13

Toxicity

Toxicity

Слайд 14

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance


Слайд 15

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance


Слайд 16

Idiosyncrasy Genetically determined abnormal response to a drug

Idiosyncrasy

Genetically determined
abnormal response to a drug

Слайд 17

Example 1 Succinyl choline in pseudocholine esterase deficiency subjects

Example 1

Succinyl choline in
pseudocholine esterase deficiency subjects

Слайд 18

Example 2 Chloroquine, salicylates, sulfa drugs in glucose 6-phosphate dehydrogenase deficiency subjects

Example 2

Chloroquine, salicylates, sulfa drugs in
glucose 6-phosphate dehydrogenase
deficiency subjects

Слайд 19

Glutathione (GSH) NADP+ NADPH + H+ Glutathione disulfide (GSSG) The Glutathione

Glutathione (GSH)

NADP+

NADPH + H+

Glutathione disulfide (GSSG)

The Glutathione Redox System

SH

SH

Glutathione
Reductase

FAD

Glucose-6-P
Dehydrogenase

Glucose- 6-phosphate

6-Phospho gluconolactone

x

x

x

Слайд 20

Example 3 Isoniazide in slow, fast acetylators

Example 3

Isoniazide in slow, fast acetylators

Слайд 21

Isoniazide Slow acetylator Fast acetylator Isoniazide metabolites

Isoniazide

Slow acetylator

Fast acetylator

Isoniazide

metabolites

Слайд 22

Drug reponse Normal therapeutic response Side effects Exaggeration of pharmacological effect Toxicities Abnormal response Tolerance

Drug reponse

Normal therapeutic response

Side effects

Exaggeration of pharmacological effect

Toxicities

Abnormal response

Tolerance

Слайд 23

Tolerance Decreased therapeutic efficacy on repeated administration over days or months.

Tolerance

Decreased therapeutic efficacy
on repeated administration over
days or months.

Слайд 24

Tachyphylaxis (desensitization) Rapidly developing tolerance

Tachyphylaxis (desensitization)

Rapidly developing tolerance

Слайд 25

Resistance (Refractoriness) Loss of therapeutic efficacy

Resistance (Refractoriness)

Loss of therapeutic efficacy

Слайд 26

Types of tolerance Acquired Congenital

Types of tolerance

Acquired

Congenital

Слайд 27

Acquired tolerance Due to repeated administration of a drug Pharmacokinetic Pharmacodynamic

Acquired tolerance

Due to repeated administration of a drug

Pharmacokinetic

Pharmacodynamic

Слайд 28

Pharmacokinetic tolerance barbiturates cause tolerance of concomitantly administered drugs

Pharmacokinetic tolerance

barbiturates cause tolerance
of
concomitantly administered drugs

Слайд 29

Pharmacodynamic tolerance Conformational changes in receptor due to long use of

Pharmacodynamic tolerance

Conformational changes in receptor due to long use of

agonist, or disruption of receptor effectors linkage, or down regulation of receptor
Exhaustion of mediators in case of amphetamine
Слайд 30

EFFECTOR RESPONSE

EFFECTOR

RESPONSE

Слайд 31

Congenital tolerance Natural inborn tolerance to certain drug which has been never used before

Congenital tolerance

Natural inborn tolerance to certain drug
which has been never

used before
Слайд 32

Congenital tolerance Racial Ephedrine is not effective mydriatic in black colored people

Congenital tolerance

Racial

Ephedrine is not effective mydriatic in
black colored people


Слайд 33

Congenital tolerance Species Rabbits tolerate large quantities of atropine without toxicity

Congenital tolerance

Species

Rabbits
tolerate large quantities of
atropine without toxicity


Слайд 34

Congenital tolerance Individual

Congenital tolerance

Individual

Слайд 35

Kymograph

Kymograph

Слайд 36

Drum Water bath Organ bath

Drum

Water bath

Organ bath

Слайд 37

Conditions Physiological solution Temperature Aeration

Conditions
Physiological solution
Temperature
Aeration

Слайд 38

Physiological solution NaCl & KCl CaCl2 Mg salt NaHCO3 NaH2PO4 Glucouse For isotonicity

Physiological solution

NaCl & KCl

CaCl2

Mg salt

NaHCO3

NaH2PO4

Glucouse

For isotonicity

Слайд 39

Physiological solution NaCl & KCl CaCl2 Mg salt NaHCO3 NaH2PO4 Glucouse Contractility

Physiological solution

NaCl & KCl

CaCl2

Mg salt

NaHCO3

NaH2PO4

Glucouse

Contractility

Слайд 40

Physiological solution NaCl & KCl CaCl2 Mg salt NaHCO3 NaH2PO4 Glucouse Contractility

Physiological solution

NaCl & KCl

CaCl2

Mg salt

NaHCO3

NaH2PO4

Glucouse

Contractility

Слайд 41

Physiological solution NaCl & KCl CaCl2 Mg salt NaHCO3 NaH2PO4 Glucouse Buffering action

Physiological solution

NaCl & KCl

CaCl2

Mg salt

NaHCO3

NaH2PO4

Glucouse

Buffering action

Слайд 42

Physiological solution NaCl & KCl CaCl2 Mg salt NaHCO3 NaH2PO4 Glucouse Nutrition

Physiological solution

NaCl & KCl

CaCl2

Mg salt

NaHCO3

NaH2PO4

Glucouse

Nutrition

Слайд 43

Temperature 36-37˚C

Temperature
36-37˚C

Слайд 44

Aeriation Pure O2 Carbogen (90% O2 + 10% CO2) Air

Aeriation

Pure O2

Carbogen (90% O2 + 10% CO2)

Air

Слайд 45

Our isolated organ Rabbit intestine Tyrode‘s solution Temperature 37˚C Aeration by air pump

Our isolated organ

Rabbit intestine
Tyrode‘s solution
Temperature 37˚C
Aeration by air pump

Слайд 46

Слайд 47

0.1 0.2 0.3 0.4 Myogenic contraction wash

0.1

0.2

0.3

0.4

Myogenic contraction

wash

Слайд 48

Donot forget

Donot forget

Слайд 49